Peptides with anticancer use or potential.

Area of Science:

• Oncology
• Peptide Therapeutics
• Drug Discovery

Background:

• Peptides represent a diverse class of molecules with significant therapeutic potential in oncology.
• Identifying and classifying peptides based on their mechanism of action is crucial for advancing cancer treatment strategies.
• A comprehensive review of existing literature is needed to understand the landscape of peptide-based anticancer agents.

Purpose of the Study:

• To systematically review and categorize peptides with established or potential applications in cancer therapy.
• To provide an overview of modern anticancer research targets as illustrated by peptide development.
• To cover patents and publications on anticancer peptides up to the early 2000s.

Main Methods:

• Literature review encompassing patents and publications up to 2000, with extensions into 2001-2002.
• Classification of peptides into five categories based on their proposed or confirmed biological mechanisms of action.
• Categorization includes receptor-interacting compounds, protein-protein interaction inhibitors, enzyme inhibitors, nucleic acid-interacting compounds, and peptides with unknown mechanisms.

Main Results:

• The review illustrates the wide diversity of peptides investigated for cancer therapy.
• Peptides are categorized by mechanisms including receptor interaction, protein-protein interaction inhibition, enzyme inhibition, and nucleic acid interaction.
• A significant portion of the reviewed peptides target modern anticancer research areas.

Conclusions:

• Peptide-based therapeutics offer a diverse range of mechanisms for cancer treatment.
• Understanding these mechanisms is key to developing novel anticancer drugs.
• This review provides a foundational overview of anticancer peptides and their targets.